Jericho Financial LLP Takes $3.14 Million Position in Chemed Co. (NYSE:CHE)

Jericho Financial LLP acquired a new position in Chemed Co. (NYSE:CHE - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 5,931 shares of the company's stock, valued at approximately $3,142,000. Chemed comprises 2.3% of Jericho Financial LLP's investment portfolio, making the stock its 22nd largest holding.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. UMB Bank n.a. lifted its holdings in shares of Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after acquiring an additional 39 shares during the last quarter. Trust Co. of Vermont purchased a new stake in Chemed in the fourth quarter worth approximately $34,000. GAMMA Investing LLC grew its position in Chemed by 60.5% during the third quarter. GAMMA Investing LLC now owns 138 shares of the company's stock valued at $83,000 after acquiring an additional 52 shares during the last quarter. Sound Income Strategies LLC purchased a new position in shares of Chemed during the third quarter worth approximately $201,000. Finally, Farther Finance Advisors LLC grew its holdings in shares of Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after purchasing an additional 324 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Chemed news, VP Brian C. Judkins bought 145 shares of the company's stock in a transaction dated Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the acquisition, the vice president now owns 1,678 shares in the company, valued at approximately $871,721. This represents a 9.46 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares of the company's stock, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on CHE. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their price target on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.

Chemed Price Performance

NYSE:CHE traded down $3.31 during trading hours on Friday, hitting $550.53. The company had a trading volume of 69,735 shares, compared to its average volume of 94,463. The stock has a 50-day moving average price of $543.17 and a 200 day moving average price of $564.44. The company has a market capitalization of $8.29 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 2.16 and a beta of 0.48. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $654.62.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.